Press Releases about Lexaria Bioscience Corp
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Comments Regarding Study Examining Cannabinoids and SARS-CoV-2
January 18, 2022
Via CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2
January 18, 2022
Via AccessWire
Lexaria Enters One-Year Media Outreach Agreement with SRAX, Inc.
December 16, 2021
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|